tradingkey.logo
tradingkey.logo
Search

BNB Plus Ord Shs

BNBX
Add to Watchlist
0.163USD
0.0000.00%
Close 07-13 16:00(ET)
836.63KMarket Cap
0.00P/E TTM

About BNB Plus Ord Shs Company

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

BNB Plus Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of BNB Plus Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-0.01%
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
--
--
Mr. Patrick Horsman
Mr. Patrick Horsman
Chief Investment Officer
Chief Investment Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-0.01%

FAQs

Who are the top five shareholders of BNB Plus Ord Shs?

The top five shareholders of BNB Plus Ord Shs are: Dr. Yacov A. Shamash, Ph.D.

What is the biggest source of revenue for BNB Plus Ord Shs?

In 2026Q4, the Product and authentication services - Large scale DNA production business generated the highest revenue for BNB Plus Ord Shs, amounting to 423.01K and accounting for 74.82% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.